CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout
← All indications

Fasting

Abstaining from FOOD.

Subtype terms (1)

More specific conditions that are subtypes of Fasting in the MeSH hierarchy.

  • Intermittent Fasting

Drugs by status

Phase 4 trials (8)

  • ibuprofen
  • hydrocortisone
  • acetaminophen
  • magnesium sulfate
  • dexmedetomidine
  • prednisolone
  • sodium chloride
  • etoricoxib

Phase 3 trials (7)

  • doravirine
  • tenofovir
  • lamivudine
  • cyclosporine
  • emtricitabine
  • bictegravir
  • tenofovir alafenamide

Phase 2 trials (3)

  • metreleptin
  • apixaban
  • gadopiclenol

Phase 1 trials (54)

  • metformin
  • allopurinol
  • 18f-ftc-146
  • sorafenib
  • procaine benzylpenicillin
  • lamotrigine
  • cilastatin
  • etodolac
  • galantamine
  • enzalutamide
  • glycine
  • tak-828
  • amlodipine
  • insulin human
  • icosapent ethyl
  • carbamazepine
  • levodopa
  • carbidopa
  • irbesartan
  • olanzapine
  • omega-3-carboxylic acids
  • terbinafine
  • risperidone
  • sitagliptin
  • mycophenolate
  • sulfatinib
  • tak-058
  • tak-137
  • pantoprazole
  • vildagliptin
  • +24 more

Other trials (15)

  • maltodextrin
  • vitamin d3
  • beta-hydroxyisovaleric acid
  • fiber
  • tamsulosin
  • insulin glargine
  • whey protein
  • leucine
  • levobupivacaine
  • domperidone
  • solifenacin
  • chlorhexidine
  • dexamethasone
  • water
  • dextrose

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.